PE anti-mouse CD45.1 Antibody
- 产品名称:
- PE anti-mouse CD45.1 Antibody
- 产品类别:
- 抗体
- 产品编号:
- 110707
- 产品应用:
- 110707
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- SJL mouse thymocytes and splenocytes
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The CD45.1 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
The A20 antibody does not react with leukocytes or?mouse cells expressing the CD45.2 alloantigen. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation3, in vitro blocking of B cell responses1,2, immunohistochemical staining of frozen sections: OCT embedded7 and acetone-fixed4-6 (direct immunofluorescence detection with fluorochrome conjugated A20 was used in (5) and (6)).
- Application References
(PubMed link indicates BioLegend citation) -
- Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
- Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
- Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
- Suzuki K, et al. 2000. Immunity 13:691. (IHC-F)
- Werner N, et al. 2002. Arterioscler. Thromb. Vasc. Biol. 22:1567. (IHC-F)
- Lessner SM, et al. 2002. Am. J. Pathol. 160:2145. (FC, IHC-F)
- Chen CC, et al. 2005. P. Natl. Acad. Sci. USA 102:11408 (IHC-F)
- Pascal V, et al. 2007. J. Immunol. 179:1751. (FC)
- Mende I, et al. 2006. Blood 107:1383. (IHC-F, FC)
- Phan TG, et al. 2007. Nature Immunol. 8:992. (FC)
- Wither DR, et al. 2009. J. Immunol. 183:5079. PubMed
- Pascal V, et al.2007. J. Immunol. 179:1751. PubMed
- Lee SW, et al. 2009. J. Immunol. 182:6753. PubMed
- Takada K, et al. 2009. J. Exp Med. 206:2253. PubMed
- Beamer CA, et al. 2007. Am. J. Respir. Cell. Mol. Biol. 37:729. (FC) PubMed
- Li LX, et al. 2010. J. Immunol. 184:1728. PubMed
- Hosoi A, et al. 2008. Cancer Res. 68:3941. (FC) PubMed
- Kenna TJ, et al. 2008. Blood 111:2091. PubMed
- Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
- Product Citations
-
- Takihara Y, et al. 2022. Commun Biol. 5:776. PubMed
- Miranda K, et al. 2022. iScience. 25:104994. PubMed
- Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
- Weiberg D, et al. 2018. PLoS One. 13:e0205247. PubMed
- Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
- Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
- Koh CH, et al. 2020. Cancer Immunol Res. 8:698. PubMed
- McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
- Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
- Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
- MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
- Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
- Sano T, et al. 2021. Cell Reports. 36(8):109608. PubMed
- Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
- Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
- Bromley SK, et al. 2020. Cell Reports. 32(9):108085. PubMed
- Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
- Ron–Harel N, et al. 2019. Cell Rep. 28:3011. PubMed
- Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
- Bowers E, et al. 2018. Nat Med. 24:95. PubMed
- Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
- Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
- LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
- Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
- Prasad M, et al. 2021. Front Immunol. 12:644483. PubMed
- Fumagalli V, et al. 2020. J Exp Med. :217. PubMed
- Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
- Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
- Yoshimi A, et al. 2019. Nature. 574:273. PubMed
- Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
- Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
- Tang Y, et al. 2015. Exp Hematol. 43: 554-564. PubMed
- Hu Z, et al. 2017. Sci Rep. 7:41558. PubMed
- Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
- Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
- Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
- Wu L, et al. 2022. Theranostics. 12:842. PubMed
- Lissner MM, et al. 2020. Elife. 9:00. PubMed
- Kaplan BLF et al. 2018. Current protocols in toxicology. 75:11:00 25. PubMed
- Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
- Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
- Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
- Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
- Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
- Bei T, et al. 2021. Molecules. 26:. PubMed
- Mansell E, et al. 2020. Cell Stem Cell. . PubMed
- Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
- Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
- Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
- Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
- LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
- Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
- Li C, et al. 2016. Nat Commun. 7:12632. PubMed
- Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
- Ma K, et al. 2022. iScience. 25:104347. PubMed
- Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
- Agrawal M, et al. 2022. Blood. 140:1094. PubMed
- Jaako P, et al. 2016. Leukemia. 10.1038/leu.2016.159. PubMed
- Ulland T, et al. 2016. Nat Commun. 7:13180. PubMed
- Winkler ES, et al. 2020. Cell. 182(4):901-918.e18. PubMed
- Evrard M et al. 2018. Immunity. 48(2):364-379 . PubMed
- Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
- Li J, et al. 2011. Dev Comp Immunol. 35:872. PubMed
- Pfau S, et al. 2016. Genes Dev. 30: 1395 - 1408. PubMed
- Danzer H, et al. 2020. Elife. 9:00. PubMed
- Field CS, et al. 2020. Cell Metab. 31:422. PubMed
- Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
- Kwok I, et al. 2020. Immunity. 53(2):303-318.e5. PubMed
- Halvarsson C, et al. 2019. Antioxid Redox Signal. 31:211. PubMed
- Luo H, et al. 2019. Cell Rep. 26:945. PubMed
- Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
- Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
- Waldman MM, et al. 2022. Front Immunol. 13:856977. PubMed
- Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
- Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
- Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
- RRID
- AB_313496 (BioLegend Cat. No. 110707) AB_313497 (BioLegend Cat. No. 110708)
- Structure
- Protein tyrosine phosphatase (PTP) family, 180-240 kD
- Distribution
-
All hematopoietic cells except mature erythrocytes and platelets of the CD45.1 strain of mice
- Function
- Phosphatase, T and B cell activation
- Ligand/Receptor
- Galectin-1, CD2, CD3, CD4
- Biology Area
- Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
- Molecular Family
- CD Molecules
- Antigen References
-
1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.
- Gene ID
- 19264 View all products for this Gene ID
- UniProt
- View information about CD45.1 on UniProt.org